BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 12789465)

  • 21. Accelerated postoperative radiotherapy with weekly concomitant boost in patients with locally advanced head and neck cancer.
    Zouhair A; Azria D; Pasche P; Stupp R; Chevalier J; Betz M; Mirimanoff RO; Ozsahin M
    Radiother Oncol; 2004 Feb; 70(2):183-8. PubMed ID: 15028406
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Simultaneous radio- and chemotherapy for squamous cell carcinoma of the head and neck in daily clinical practice: 5 years experience in a University Hospital.
    Langenberg M; Terhaard CH; Hordijk GJ; Es RJ; Voest EE; Graeff A
    Clin Otolaryngol Allied Sci; 2004 Dec; 29(6):729-34. PubMed ID: 15533169
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Feasibility study of single agent Cisplatin and concurrent radiotherapy in Japanese patients with squamous cell carcinoma of the head and neck: preliminary results.
    Zenda S; Onozawa Y; Tahara M; Kawashima M; Shikama N; Sasaki S; Boku N
    Jpn J Clin Oncol; 2007 Oct; 37(10):725-9. PubMed ID: 17925299
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Impact of late treatment-related toxicity on quality of life among patients with head and neck cancer treated with radiotherapy.
    Langendijk JA; Doornaert P; Verdonck-de Leeuw IM; Leemans CR; Aaronson NK; Slotman BJ
    J Clin Oncol; 2008 Aug; 26(22):3770-6. PubMed ID: 18669465
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Evaluation of prognostic factors and two radiation techniques in patients treated with surgery followed by radio(chemo)therapy or definitive radio(chemo)therapy for locally advanced head-and-neck cancer.
    Rades D; Stoehr M; Meyners T; Bohlen G; Nadrowitz R; Dunst J; Schild SE; Wroblewski J; Albers D; Schmidt R; Alberti W; Tribius S
    Strahlenther Onkol; 2008 Apr; 184(4):198-205. PubMed ID: 18398584
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Radiation-induced volume changes in parotid and submandibular glands in patients with head and neck cancer receiving postoperative radiotherapy: a longitudinal study.
    Wang ZH; Yan C; Zhang ZY; Zhang CP; Hu HS; Kirwan J; Mendenhall WM
    Laryngoscope; 2009 Oct; 119(10):1966-74. PubMed ID: 19688858
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Patterns of failure in patients with locally advanced head and neck cancer treated postoperatively with irradiation or concomitant irradiation with Mitomycin C and Bleomycin.
    Zakotnik B; Budihna M; Smid L; Soba E; Strojan P; Fajdiga I; Zargi M; Oblak I; Lesnicar H
    Int J Radiat Oncol Biol Phys; 2007 Mar; 67(3):685-90. PubMed ID: 17197122
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Low-dose fractionated radiation as a chemopotentiator of neoadjuvant paclitaxel and carboplatin for locally advanced squamous cell carcinoma of the head and neck: results of a new treatment paradigm.
    Arnold SM; Regine WF; Ahmed MM; Valentino J; Spring P; Kudrimoti M; Kenady D; Desimone P; Mohiuddin M
    Int J Radiat Oncol Biol Phys; 2004 Apr; 58(5):1411-7. PubMed ID: 15050317
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Phase II study of palifermin and concurrent chemoradiation in head and neck squamous cell carcinoma.
    Brizel DM; Murphy BA; Rosenthal DI; Pandya KJ; Glück S; Brizel HE; Meredith RF; Berger D; Chen MG; Mendenhall W
    J Clin Oncol; 2008 May; 26(15):2489-96. PubMed ID: 18487568
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Altered fractionation and/or adjuvant chemotherapy in definitive irradiation of squamous cell carcinoma of the head and neck.
    Mendenhall WM; Riggs CE; Amdur RJ; Hinerman RW; Villaret DB
    Laryngoscope; 2003 Mar; 113(3):546-51. PubMed ID: 12616212
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Neoadjuvant accelerated chemotherapy followed by hyperfractionated radiation therapy in patients with operable, locally advanced head and neck carcinoma.
    Franchin G; Vaccher E; Gobitti C; Minatel E; Politi D; Talamini R; Di Gennaro G; Savignano G; Trovò MG; Tirelli U; Barzan L
    Oral Oncol; 2005 May; 41(5):526-33. PubMed ID: 15878759
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hypofractionated radiotherapy denoted as the "Christie scheme": an effective means of palliating patients with head and neck cancers not suitable for curative treatment.
    Al-mamgani A; Tans L; Van rooij PH; Noever I; Baatenburg de jong RJ; Levendag PC
    Acta Oncol; 2009; 48(4):562-70. PubMed ID: 19373698
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Randomized trial of postoperative reirradiation combined with chemotherapy after salvage surgery compared with salvage surgery alone in head and neck carcinoma.
    Janot F; de Raucourt D; Benhamou E; Ferron C; Dolivet G; Bensadoun RJ; Hamoir M; Géry B; Julieron M; Castaing M; Bardet E; Grégoire V; Bourhis J
    J Clin Oncol; 2008 Dec; 26(34):5518-23. PubMed ID: 18936479
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Early experience with a hybrid accelerated radiotherapy schedule for locally advanced head and neck cancer.
    Nuyts S; Dirix P; Hermans R; Poorten VV; Delaere P; Weltens C; Van den Bogaert W
    Head Neck; 2007 Aug; 29(8):720-30. PubMed ID: 17315171
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Intensity-modulated radiation treatment for head-and-neck squamous cell carcinoma--the University of Iowa experience.
    Yao M; Dornfeld KJ; Buatti JM; Skwarchuk M; Tan H; Nguyen T; Wacha J; Bayouth JE; Funk GF; Smith RB; Graham SM; Chang K; Hoffman HT
    Int J Radiat Oncol Biol Phys; 2005 Oct; 63(2):410-21. PubMed ID: 16168834
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Treatment of patients with unresectable squamous head and neck cancer with induction chemotherapy followed by hyperfractionated radiotherapy.
    Mesía R; Majem M; Barretina Ginesta MP; Galiana R; Mañós M; Guedea F; Montes A; Monner A; Pérez J; Cardenal F
    Cancer Radiother; 2008 Mar; 12(2):88-95. PubMed ID: 18155633
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Long-term neck control rates after complete response to chemoradiation in patients with advanced head and neck cancer.
    Rengan R; Pfister DG; Lee NY; Kraus DH; Shah JP; Shaha AR; Ben-Porat LS; Zelefsky MJ
    Am J Clin Oncol; 2008 Oct; 31(5):465-9. PubMed ID: 18838883
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The comparison of weekly and three-weekly cisplatin chemotherapy concurrent with radiotherapy in patients with previously untreated inoperable non-metastatic squamous cell carcinoma of the head and neck.
    Uygun K; Bilici A; Karagol H; Caloglu M; Cicin I; Aksu G; Fayda M; Uzunoglu S
    Cancer Chemother Pharmacol; 2009 Aug; 64(3):601-5. PubMed ID: 19123002
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Concurrent chemoradiotherapy with cisplatin and fluorouracil for locally advanced hypopharyngeal carcinoma.
    Yoon MS; Chung WK; Ahn SJ; Nam TK; Nah BS; Song JY; Lim SC; Lee JK
    Acta Otolaryngol; 2008 May; 128(5):590-6. PubMed ID: 18421617
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hyperfractionated accelerated radiotherapy alone and with concomitant chemotherapy to the head and neck: treated within and outside of randomized clinical trials.
    Hehr T; Classen J; Schreck U; Glocker S; Bamberg M; Budach W
    Int J Radiat Oncol Biol Phys; 2004 Apr; 58(5):1424-30. PubMed ID: 15050319
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.